Others

Shop By

Items 1-50 of 83

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. Hyaluronan (HA) synthesis inhibitor

    4-Methylumbelliferone is a selective inhibitor of Hyaluronan (HA) synthesis which is thought to function as an inhibitor via the depletion of UDP-glucuronic acid, the common substrate for HA synthesis.
  2. Hydrogen peroxide inhibitor

    Acetanilide is used as an inhibitor in hydrogen peroxide and is used to stabilize cellulose ester varnishes.
  3. DprE1 inhibitor

    BTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-β-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
  4. Monoamine reuptake inhibitor

    Diclofensine (Ro 8-4650) acts as a triple monoamine reuptake inhibitor, primarily inhibiting the reuptake of dopamine and noradrenaline.
  5. O-GlcNAcase inhibitor

    Streptozotocin (Streptozocin, Zanosar, STZ)is used in medical research to produce an animal model for Type 1 diabetes, which directly inhibist the O-GlcNAcase activity of the enzyme NCOAT in vitro.
  6. dipeptidase inhibitor

    Cilastatin is a dipeptidase inhibitor that specifically inhibits DPEP1 (dehydrodipeptidase I), a renal membrane-bound glycoprotein involved in the hydrolytic metabolism of penem and carbapenem ??-lactam antibiotics.
  7. HPPD inhibitor

    Nitrisinone is a competitive inhibitor that reversibly inhibits 4-Hydroxyphenylpyruvate oxidase (dioxygenase).
  8. ARFGAP1 inhibitor

    QS-11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor.
  9. BCRP inhibitor

    Ko 143 is potent and selective inhibitor of breast cancer resistance protein multidrug transporter (BCRP) with an EC90 value of 26 nM.
  10. micromolar inhibitor

    Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A virus and influenza B virus.
  11. MCP inhibitor

    Bindarit is an anti-inflammatory small molecule that modulates the NFκB pathway.
  12. Mad2 inhibitor

    M2I-1 is a Mad2 inhibitor targeting the binding of Mad2 to Cdc20, an essential protein-protein interaction (PPI) within the spindle assembly checkpoint (SAC).
  13. Visual cycle isomerase inhibitor

    Emixustat, a novel visual cycle modulator, is an inhibitor of the visual cycle isomerase with an IC50 value of 4.4 nM in vitro.
  14. O-GlcNAcase inhibitor

    Thiamet G is a potent, selective O-GlcNAcase inhibitor with Kiof 21 nM, while exhibiting 37,000-fold selectivity over human lysosomal-hexosaminidase.
  15. SCD1 inhibitor

    stearoyl-CoA desaturase 1 (SCD1) inhibitor. Used to selectively eliminate undifferentiated human pluripotent stem cells (hPSCs) from culture; induces ER stress, attenuates protein synthesis and induces apoptosis in hPSCs. Prevents teratoma formation in immunocompromised mice.
  16. NMD inhibitor

    NMDI14 is a nonsense mediated RNA decay (NMD) inhibitor.
  17. AKR1C3 inhibitor

    AKR1C3-IN-1 is a potent, highly selective inhibitor of AKR1C3, with an IC50 of 13 nM.
  18. GSNOR inhibitor

    N6022 is a potent, specific, and fully reversible inhibitor of S-nitrosoglutathione reductase (GSNOR) with an IC50 of 8 nM and a Ki of 2.5 nM.
  19. exocytic inhibitor

    Exo1 is a chemical inhibitor of the exocytic pathway.
  20. acetyl-CoA carboxylase inhibitor

    CP-640186 is an isozyme-nonselective acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively; with improved metabolic stability vs CP-610431.
  21. CerK inhibitor

    NVP-231 is a potent, specific, and reversible CerK inhibitor that competitively inhibits binding of ceramide to CerK.
  22. protein synthesis inhibitor

    Apramycin Sulfate is a broad spectrum aminocyclitol antibiotic and component of the Nebramycin complex, produced by a strain of Streptomyces tenebrarius
  23. helicase primase inhibitor

    BAY 57-1293 is a potent helicase primase inhibitor. BAY 57-1293 inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase-helicase complex.
  24. Noradrenalin re-uptake inhibitor

    Nisoxetine hydrochloride is a selective and potent inhibitor of norepinephrine transporter with little or no affinity for a range of other neurotransmitter receptors. Nisoxetine hydrochloride is an inhibitor of SLC6A2.
  25. dual Arf1/Arf6 activation inhibitor

    NAV-2729 is a dual Arf1/Arf6 activation inhibitor.
  26. PKR Inhibitor

    PKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.3 PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.
  27. Haspin inhibitor

    CHR-6494 is a potent and selective Haspin (Haploid Germ Cell-Specific Nuclear Protein Kinase) inhibitor that blocks H3T3ph phosphorylation.
  28. VMAT2 inhibitor

    GZ-793A is a selective inhibitor of vesicular monoamine transporter 2 (VMAT2), which transports the monoamine neurotransmitters from cellular cytosol into synaptic vesicles.
  29. ENT1 inhibitor

    NBMPR is a nucleoside analog that competitively inhibits the equilibrative nucleoside transporter 1 (Kd = 0.1-1.0 nM, IC50s = 4.6 and 3.6 nM in rat and human, respectively).
  30. Treprostinil is a stable analog of prostacyclin that is used clinically for the treatment of PPH.
  31. leukemia inhibitory factor (LIF) inhibitor

    EC330 is a leukemia inhibitory factor (LIF) inhibitor.
  32. OSC Inhibitor

    Ro 48-8071 is an inhibitor of OSC(Oxidosqualene cyclase; IC50=6.5 nM) that has low-density lipoprotein (LDL) cholesterol lowering activity.
  33. NQO1 inhibitor

    Dicoumarol is a competitive NADH quinone oxidoreductase (NQO1) inhibitor.
  34. cholinephosphotransferase inhibitor

    Meclofenoxate HCl is an anti-aging drug used to treat the symptoms of senile dementia and Alzheimer's disease, and also inhibits the activity of cholinephosphotransferase.
  35. Factor VIIa Inhibitor

    PCI-27483 is a reversible small-molecule inhibitor of activated factor VII (factor VIIa) with potential antineoplastic and antithrombotic activities.
  36. c-Fos inhibitor

    T-5224 is a selective inhibitor of c-Fos/activator protein-1.
  37. Cell adhesion inhibitor

    K-7174 is a novel cell adhesion inhibitor; inhibits the expression of vascular cell adhesion molecule-1 (VCAM-1) induced by either IL-1beta or TNF-alpha.
  38. Cell adhesion inhibitor

    K-7174 dihydrochloride is a novel cell adhesion inhibitor; inhibits the expression of vascular cell adhesion molecule-1 (VCAM-1) induced by either IL-1beta or TNF-alpha.
  39. CBFBeta-SMMHC / RUNX1 inhibitor

    AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBFβ-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM,
  40. DprE1 inhibitor

    AZ7371 is a a novel non-covalent DprE1 inhibitor.
  41. arginase inhibitor

    BEC HCl is a slow-binding, and competitive arginase inhibitor with Ki of 0.31 μM (pH7.5) and 0.4-0.6 μM for Arginase II and rat Arginase I, respectively.
  42. polyamine synthesis inhibitor

    Sardomozide is a second-generation polyamine synthesis inhibitor, which inhibits the activity of the polyamine biosynthetic enzyme S-adenosylmethionine decarboxylase (SAMDC).
  43. ABHD6 inhibitor

    WWL70 is a potent inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50 = 70 nM), an enzyme which catalyzes the hydrolysis of 2-arachidonylglycerol.
  44. PPCE inhibitor

    Y-29794 Tosylate is an orally active, potent and specific non-peptide prolyl endopeptidase (PPCE) inhibitor.
  45. LSC inhibitor

    BRD 7116 is a potent and selective Inhibitor of leukemia stem cell (LSC) activity (EC50 = 200 nM).
  46. Fibrillogenesis inhibitor

    Eprodisate is an orally available disodium salt form of eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.
  47. VMAT2 inhibitor

    Valbenazine is a potent and selective VMAT2 inhibitor.
  48. Cytohesin inhibitor

    SecinH3 is a selective cytohesin inhibitor with IC50 of 2.4 μM, 5.4 μM, 5.4 μM, 5.6 μM, 5.6 μM, and 65 μM for hCyh2, hCyh1, mCyh3, hCyh3, drosophila steppke, and yGea2-S7, respectively.
  49. Rio2 kinase (RIOK2) inhibitor

    NSC139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC50s ranging from 30 to 400 nM.
  50. LOXL2 inhibitor

    LOXL2-IN-1 HCl is a selective LOXL2 inhibitor with an IC50 of 126 nM.

Items 1-50 of 83

Page
per page
Set Descending Direction